I write this having just returned from a whistle-stop visit to Berlin, where I have been supporting the Mayor’s campaign to encourage collaboration between London and Europe in light of Article 50 being triggered this week. Of course, as always, I was there to represent the whole of the Golden Triangle of London, Oxford and Cambridge. It was a pleasure to chair a panel around innovation with key players from Germany and I had chance to meet some exciting companies on the Mayor’s International Business Programme, including Diabetology – based in London, but working with both Oxford and Cambridge – Medical Realities and StepJockey.
This month, we also announced the winners of our £2m Collaborate to Innovate programme. I’m excited for this diverse range of SME-academic partnerships to get started and we’ll keep you updated on their progress. Read below to find out about the winners.
This week we also worked with Liftstream, a life sciences executive recruiter, to host an event looking at solutions to the lack of diversity on BioPharma boardrooms. Over 150 people attended to see industry leaders share their honest experiences and how they think we can tackle this important issue. MedCity board member Annalisa Jenkins chaired one of the panels and we have been well supported by members of our Advisory Board in this work. We will be sharing a report soon but, in the meantime, do let me know what actions you think could be taken to improve diversity on life sciences boards over on Twitter @MedCityHQ